A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.

Clinical trial NCT02271217 · COMPLETED

Trial details

NCT number: NCT02271217
Sponsor: Acorda Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Post-Ischemic Stroke

Start date: 2014-12-01
Primary completion: 2016-09-01
Enrollment: 377

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.